Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed, GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B (rDNA) vaccine (adjuvanted, adsorbed, GlaxoSmithKline)
Drug Alias Name้‡็ป„ไน™ๅž‹่‚็‚Ž็–ซ่‹— SBAS4HBs-AG/AS-04Hepatitis B vaccine recombinant SBAS4FendrixSB-M-00026 +[6]ย 
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2005/02/01
Country/TerritoryBelgiumCanadaSweden +[4]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Biologicals SA
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ07BC01
Related LinksN/A